Showing results (111-120 of 139) with videos related to
Sort By:
Pageof 14
Trials|August 22, 2024
Advancing spatial repellents for malaria control: effectiveness and cost-effectiveness of a spatial repellent under operational use in Northern Uganda-study protocol for a cluster randomized controlled trialEsther Nakyaze, Suzanne Van Hulle, John Hembling, et al.BMC Public Health|February 14, 2020
Knowledge, attitudes and practices assessment of malaria interventions in rural ZambiaDesmond T Jumbam, Jennifer C Stevenson, Japhet Matoba, et al.Frontiers in Oncology|February 1, 2021
Progression-Mediated Changes in Mitochondrial Morphology Promotes Adaptation to Hypoxic Peritoneal Conditions in Serous Ovarian CancerJoseph P Grieco, Mitchell E Allen, Justin B Perry, et al.British Journal of Pharmacology|January 25, 2007
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damageD Giuliani, C Mioni, C Bazzani, et al.Malaria Journal|May 16, 2012
Spatial repellents: from discovery and development to evidence-based validationNicole L Achee, Michael J Bangs, Robert Farlow, et al.Journal of Medical Entomology|October 6, 2017
Molecular Detection and Identification of Rickettsia Species in Ticks (Acari: Ixodidae) Collected From Belize, Central AmericaSuppaluck Polsomboon, David F Hoel, Jittawadee R Murphy, et al.Mediators of Inflammation|March 8, 2016
Activation of Melanocortin Receptors MC 1 and MC 5 Attenuates Retinal Damage in Experimental Diabetic RetinopathyS Rossi, R Maisto, C Gesualdo, et al.Malaria Journal|January 23, 2024
Impact of a spatial repellent intervention on Anopheles kdr insecticide resistance allele in Sumba, IndonesiaLepa Syahrani, Puji B S Asih, Anom Bowolaksono, et al.Mediators of Inflammation|April 19, 2021
Corrigendum to "Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy"S Rossi, R Maisto, C Gesualdo, et al.Trials|November 3, 2023
EaveTubes for control of vector-borne diseases in Côte d'Ivoire: study protocol for a cluster randomized controlled trialRaphael N'Guessan, Serge-Brice Assi, Alphonsine Koffi, et al.Pageof 14